Global Human Papillomavirus (HPV) Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 116

Published Date: 03 Jul 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Human Papillomavirus (HPV) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Human Papillomavirus (HPV) Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Human Papillomavirus (HPV) Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Human Papillomavirus (HPV) Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Pap Smear Test
HPV DNA Test

Market segment by Application, can be divided into
Diagnostic Centers
Hospitals
Clinic

Market segment by players, this report covers
Roche
Agilent Technologies
Becton, DickinsonandCompany
QiagenN.V.
Thermo FisherScientificInc.
Abbott Laboratories
HologicInc.
CepheidInc.
SeegeneInc.
TakaraBio Inc.
DaAnGeneof SunYat-SenUniversity
PromegaCorporation
GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
Enzo Biochem Inc.
NorgenBiotek
DiagCorBioscienceIncLtd
Hybribio Limited
ZytovisionGmbH
ArborVitaCorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Human Papillomavirus (HPV) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Human Papillomavirus (HPV) Testing, with revenue, gross margin and global market share of Human Papillomavirus (HPV) Testing from 2019 to 2021.
Chapter 3, the Human Papillomavirus (HPV) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Human Papillomavirus (HPV) Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Human Papillomavirus (HPV) Testing research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Human Papillomavirus (HPV) Testing
    1.2 Classification of Human Papillomavirus (HPV) Testing by Type
        1.2.1 Overview: Global Human Papillomavirus (HPV) Testing Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type in 2020
        1.2.3 Pap Smear Test
        1.2.4 HPV DNA Test
    1.3 Global Human Papillomavirus (HPV) Testing Market by Application
        1.3.1 Overview: Global Human Papillomavirus (HPV) Testing Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Diagnostic Centers
        1.3.3 Hospitals
        1.3.4 Clinic
    1.4 Global Human Papillomavirus (HPV) Testing Market Size & Forecast
    1.5 Global Human Papillomavirus (HPV) Testing Market Size and Forecast by Region
        1.5.1 Global Human Papillomavirus (HPV) Testing Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Human Papillomavirus (HPV) Testing Market Size by Region, (2016-2021)
        1.5.3 North America Human Papillomavirus (HPV) Testing Market Size and Prospect (2016-2026)
        1.5.4 Europe Human Papillomavirus (HPV) Testing Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size and Prospect (2016-2026)
        1.5.6 South America Human Papillomavirus (HPV) Testing Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Human Papillomavirus (HPV) Testing Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Human Papillomavirus (HPV) Testing Market Drivers
        1.6.2 Human Papillomavirus (HPV) Testing Market Restraints
        1.6.3 Human Papillomavirus (HPV) Testing Trends Analysis

2 Company Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Human Papillomavirus (HPV) Testing Product and Solutions
        2.1.4 Roche Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Roche Recent Developments and Future Plans
    2.2 Agilent Technologies
        2.2.1 Agilent Technologies Details
        2.2.2 Agilent Technologies Major Business
        2.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Product and Solutions
        2.2.4 Agilent Technologies Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Agilent Technologies Recent Developments and Future Plans
    2.3 Becton, DickinsonandCompany
        2.3.1 Becton, DickinsonandCompany Details
        2.3.2 Becton, DickinsonandCompany Major Business
        2.3.3 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Product and Solutions
        2.3.4 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Becton, DickinsonandCompany Recent Developments and Future Plans
    2.4 QiagenN.V.
        2.4.1 QiagenN.V. Details
        2.4.2 QiagenN.V. Major Business
        2.4.3 QiagenN.V. Human Papillomavirus (HPV) Testing Product and Solutions
        2.4.4 QiagenN.V. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 QiagenN.V. Recent Developments and Future Plans
    2.5 Thermo FisherScientificInc.
        2.5.1 Thermo FisherScientificInc. Details
        2.5.2 Thermo FisherScientificInc. Major Business
        2.5.3 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Product and Solutions
        2.5.4 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Thermo FisherScientificInc. Recent Developments and Future Plans
    2.6 Abbott Laboratories
        2.6.1 Abbott Laboratories Details
        2.6.2 Abbott Laboratories Major Business
        2.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Product and Solutions
        2.6.4 Abbott Laboratories Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Abbott Laboratories Recent Developments and Future Plans
    2.7 HologicInc.
        2.7.1 HologicInc. Details
        2.7.2 HologicInc. Major Business
        2.7.3 HologicInc. Human Papillomavirus (HPV) Testing Product and Solutions
        2.7.4 HologicInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 HologicInc. Recent Developments and Future Plans
    2.8 CepheidInc.
        2.8.1 CepheidInc. Details
        2.8.2 CepheidInc. Major Business
        2.8.3 CepheidInc. Human Papillomavirus (HPV) Testing Product and Solutions
        2.8.4 CepheidInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 CepheidInc. Recent Developments and Future Plans
    2.9 SeegeneInc.
        2.9.1 SeegeneInc. Details
        2.9.2 SeegeneInc. Major Business
        2.9.3 SeegeneInc. Human Papillomavirus (HPV) Testing Product and Solutions
        2.9.4 SeegeneInc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 SeegeneInc. Recent Developments and Future Plans
    2.10 TakaraBio Inc.
        2.10.1 TakaraBio Inc. Details
        2.10.2 TakaraBio Inc. Major Business
        2.10.3 TakaraBio Inc. Human Papillomavirus (HPV) Testing Product and Solutions
        2.10.4 TakaraBio Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 TakaraBio Inc. Recent Developments and Future Plans
    2.11 DaAnGeneof SunYat-SenUniversity
        2.11.1 DaAnGeneof SunYat-SenUniversity Details
        2.11.2 DaAnGeneof SunYat-SenUniversity Major Business
        2.11.3 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Product and Solutions
        2.11.4 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 DaAnGeneof SunYat-SenUniversity Recent Developments and Future Plans
    2.12 PromegaCorporation
        2.12.1 PromegaCorporation Details
        2.12.2 PromegaCorporation Major Business
        2.12.3 PromegaCorporation Human Papillomavirus (HPV) Testing Product and Solutions
        2.12.4 PromegaCorporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 PromegaCorporation Recent Developments and Future Plans
    2.13 GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
        2.13.1 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Details
        2.13.2 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Major Business
        2.13.3 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Product and Solutions
        2.13.4 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Developments and Future Plans
    2.14 Enzo Biochem Inc.
        2.14.1 Enzo Biochem Inc. Details
        2.14.2 Enzo Biochem Inc. Major Business
        2.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Product and Solutions
        2.14.4 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Enzo Biochem Inc. Recent Developments and Future Plans
    2.15 NorgenBiotek
        2.15.1 NorgenBiotek Details
        2.15.2 NorgenBiotek Major Business
        2.15.3 NorgenBiotek Human Papillomavirus (HPV) Testing Product and Solutions
        2.15.4 NorgenBiotek Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 NorgenBiotek Recent Developments and Future Plans
    2.16 DiagCorBioscienceIncLtd
        2.16.1 DiagCorBioscienceIncLtd Details
        2.16.2 DiagCorBioscienceIncLtd Major Business
        2.16.3 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Product and Solutions
        2.16.4 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 DiagCorBioscienceIncLtd Recent Developments and Future Plans
    2.17 Hybribio Limited
        2.17.1 Hybribio Limited Details
        2.17.2 Hybribio Limited Major Business
        2.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Product and Solutions
        2.17.4 Hybribio Limited Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 Hybribio Limited Recent Developments and Future Plans
    2.18 ZytovisionGmbH
        2.18.1 ZytovisionGmbH Details
        2.18.2 ZytovisionGmbH Major Business
        2.18.3 ZytovisionGmbH Human Papillomavirus (HPV) Testing Product and Solutions
        2.18.4 ZytovisionGmbH Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.18.5 ZytovisionGmbH Recent Developments and Future Plans
    2.19 ArborVitaCorporation
        2.19.1 ArborVitaCorporation Details
        2.19.2 ArborVitaCorporation Major Business
        2.19.3 ArborVitaCorporation Human Papillomavirus (HPV) Testing Product and Solutions
        2.19.4 ArborVitaCorporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.19.5 ArborVitaCorporation Recent Developments and Future Plans
    2.20 Medical& BiologicalLaboratoriesCo., Ltd
        2.20.1 Medical& BiologicalLaboratoriesCo., Ltd Details
        2.20.2 Medical& BiologicalLaboratoriesCo., Ltd Major Business
        2.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Product and Solutions
        2.20.4 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Developments and Future Plans
    2.21 Fujirebio Diagnostics
        2.21.1 Fujirebio Diagnostics Details
        2.21.2 Fujirebio Diagnostics Major Business
        2.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Product and Solutions
        2.21.4 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2019-2021)
        2.21.5 Fujirebio Diagnostics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Human Papillomavirus (HPV) Testing Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Human Papillomavirus (HPV) Testing Players Market Share
        3.2.2 Top 10 Human Papillomavirus (HPV) Testing Players Market Share
        3.2.3 Market Competition Trend
    3.3 Human Papillomavirus (HPV) Testing Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Human Papillomavirus (HPV) Testing Revenue and Market Share by Type (2016-2021)
    4.2 Global Human Papillomavirus (HPV) Testing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2016-2021)
    5.2 Human Papillomavirus (HPV) Testing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Human Papillomavirus (HPV) Testing Revenue by Type (2016-2026)
    6.2 North America Human Papillomavirus (HPV) Testing Revenue by Application (2016-2026)
    6.3 North America Human Papillomavirus (HPV) Testing Market Size by Country
        6.3.1 North America Human Papillomavirus (HPV) Testing Revenue by Country (2016-2026)
        6.3.2 United States Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        6.3.3 Canada Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        6.3.4 Mexico Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Human Papillomavirus (HPV) Testing Revenue by Type (2016-2026)
    7.2 Europe Human Papillomavirus (HPV) Testing Revenue by Application (2016-2026)
    7.3 Europe Human Papillomavirus (HPV) Testing Market Size by Country
        7.3.1 Europe Human Papillomavirus (HPV) Testing Revenue by Country (2016-2026)
        7.3.2 Germany Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        7.3.3 France Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        7.3.5 Russia Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        7.3.6 Italy Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Type (2016-2026)
    8.2 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Application (2016-2026)
    8.3 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region
        8.3.1 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Region (2016-2026)
        8.3.2 China Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        8.3.3 Japan Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        8.3.4 South Korea Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        8.3.5 India Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        8.3.7 Australia Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Human Papillomavirus (HPV) Testing Revenue by Type (2016-2026)
    9.2 South America Human Papillomavirus (HPV) Testing Revenue by Application (2016-2026)
    9.3 South America Human Papillomavirus (HPV) Testing Market Size by Country
        9.3.1 South America Human Papillomavirus (HPV) Testing Revenue by Country (2016-2026)
        9.3.2 Brazil Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        9.3.3 Argentina Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Type (2016-2026)
    10.2 Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Application (2016-2026)
    10.3 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country
        10.3.1 Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Country (2016-2026)
        10.3.2 Turkey Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)
        10.3.4 UAE Human Papillomavirus (HPV) Testing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Human Papillomavirus (HPV) Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Human Papillomavirus (HPV) Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Human Papillomavirus (HPV) Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Human Papillomavirus (HPV) Testing Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Region (2021-2026)
    Table 6. Roche Corporate Information, Head Office, and Major Competitors
    Table 7. Roche Major Business
    Table 8. Roche Human Papillomavirus (HPV) Testing Product and Solutions
    Table 9. Roche Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Agilent Technologies Corporate Information, Head Office, and Major Competitors
    Table 11. Agilent Technologies Major Business
    Table 12. Agilent Technologies Human Papillomavirus (HPV) Testing Product and Solutions
    Table 13. Agilent Technologies Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Becton, DickinsonandCompany Corporate Information, Head Office, and Major Competitors
    Table 15. Becton, DickinsonandCompany Major Business
    Table 16. Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Product and Solutions
    Table 17. Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. QiagenN.V. Corporate Information, Head Office, and Major Competitors
    Table 19. QiagenN.V. Major Business
    Table 20. QiagenN.V. Human Papillomavirus (HPV) Testing Product and Solutions
    Table 21. QiagenN.V. Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Thermo FisherScientificInc. Corporate Information, Head Office, and Major Competitors
    Table 23. Thermo FisherScientificInc. Major Business
    Table 24. Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Product and Solutions
    Table 25. Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
    Table 27. Abbott Laboratories Major Business
    Table 28. Abbott Laboratories Human Papillomavirus (HPV) Testing Product and Solutions
    Table 29. Abbott Laboratories Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. HologicInc. Corporate Information, Head Office, and Major Competitors
    Table 31. HologicInc. Major Business
    Table 32. HologicInc. Human Papillomavirus (HPV) Testing Product and Solutions
    Table 33. HologicInc. Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. CepheidInc. Corporate Information, Head Office, and Major Competitors
    Table 35. CepheidInc. Major Business
    Table 36. CepheidInc. Human Papillomavirus (HPV) Testing Product and Solutions
    Table 37. CepheidInc. Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. SeegeneInc. Corporate Information, Head Office, and Major Competitors
    Table 39. SeegeneInc. Major Business
    Table 40. SeegeneInc. Human Papillomavirus (HPV) Testing Product and Solutions
    Table 41. SeegeneInc. Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. TakaraBio Inc. Corporate Information, Head Office, and Major Competitors
    Table 43. TakaraBio Inc. Major Business
    Table 44. TakaraBio Inc. Human Papillomavirus (HPV) Testing Product and Solutions
    Table 45. TakaraBio Inc. Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. DaAnGeneof SunYat-SenUniversity Corporate Information, Head Office, and Major Competitors
    Table 47. DaAnGeneof SunYat-SenUniversity Major Business
    Table 48. DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Product and Solutions
    Table 49. DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. PromegaCorporation Corporate Information, Head Office, and Major Competitors
    Table 51. PromegaCorporation Major Business
    Table 52. PromegaCorporation Human Papillomavirus (HPV) Testing Product and Solutions
    Table 53. PromegaCorporation Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Corporate Information, Head Office, and Major Competitors
    Table 55. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Major Business
    Table 56. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Product and Solutions
    Table 57. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Enzo Biochem Inc. Corporate Information, Head Office, and Major Competitors
    Table 59. Enzo Biochem Inc. Major Business
    Table 60. Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Product and Solutions
    Table 61. Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. NorgenBiotek Corporate Information, Head Office, and Major Competitors
    Table 63. NorgenBiotek Major Business
    Table 64. NorgenBiotek Human Papillomavirus (HPV) Testing Product and Solutions
    Table 65. NorgenBiotek Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 66. DiagCorBioscienceIncLtd Corporate Information, Head Office, and Major Competitors
    Table 67. DiagCorBioscienceIncLtd Major Business
    Table 68. DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Product and Solutions
    Table 69. DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 70. Hybribio Limited Corporate Information, Head Office, and Major Competitors
    Table 71. Hybribio Limited Major Business
    Table 72. Hybribio Limited Human Papillomavirus (HPV) Testing Product and Solutions
    Table 73. Hybribio Limited Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 74. ZytovisionGmbH Corporate Information, Head Office, and Major Competitors
    Table 75. ZytovisionGmbH Major Business
    Table 76. ZytovisionGmbH Human Papillomavirus (HPV) Testing Product and Solutions
    Table 77. ZytovisionGmbH Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 78. ArborVitaCorporation Corporate Information, Head Office, and Major Competitors
    Table 79. ArborVitaCorporation Major Business
    Table 80. ArborVitaCorporation Human Papillomavirus (HPV) Testing Product and Solutions
    Table 81. ArborVitaCorporation Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 82. Medical& BiologicalLaboratoriesCo., Ltd Corporate Information, Head Office, and Major Competitors
    Table 83. Medical& BiologicalLaboratoriesCo., Ltd Major Business
    Table 84. Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Product and Solutions
    Table 85. Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 86. Fujirebio Diagnostics Corporate Information, Head Office, and Major Competitors
    Table 87. Fujirebio Diagnostics Major Business
    Table 88. Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Product and Solutions
    Table 89. Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 90. Global Human Papillomavirus (HPV) Testing Revenue (USD Million) by Players (2019-2021)
    Table 91. Global Human Papillomavirus (HPV) Testing Revenue Share by Players (2019-2021)
    Table 92. Breakdown of Human Papillomavirus (HPV) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 93. Human Papillomavirus (HPV) Testing Players Head Office, Products and Services Provided
    Table 94. Human Papillomavirus (HPV) Testing Mergers & Acquisitions in the Past Five Years
    Table 95. Human Papillomavirus (HPV) Testing New Entrants and Expansion Plans
    Table 96. Global Human Papillomavirus (HPV) Testing Revenue (USD Million) by Type (2016-2021)
    Table 97. Global Human Papillomavirus (HPV) Testing Revenue Share by Type (2016-2021)
    Table 98. Global Human Papillomavirus (HPV) Testing Revenue Forecast by Type (2021-2026)
    Table 99. Global Human Papillomavirus (HPV) Testing Revenue by Application (2016-2021)
    Table 100. Global Human Papillomavirus (HPV) Testing Revenue Forecast by Application (2021-2026)
    Table 101. North America Human Papillomavirus (HPV) Testing Revenue by Type (2016-2021) & (USD Million)
    Table 102. North America Human Papillomavirus (HPV) Testing Revenue by Type (2021-2026) & (USD Million)
    Table 103. North America Human Papillomavirus (HPV) Testing Revenue by Application (2016-2021) & (USD Million)
    Table 104. North America Human Papillomavirus (HPV) Testing Revenue by Application (2021-2026) & (USD Million)
    Table 105. North America Human Papillomavirus (HPV) Testing Revenue by Country (2016-2021) & (USD Million)
    Table 106. North America Human Papillomavirus (HPV) Testing Revenue by Country (2021-2026) & (USD Million)
    Table 107. Europe Human Papillomavirus (HPV) Testing Revenue by Type (2016-2021) & (USD Million)
    Table 108. Europe Human Papillomavirus (HPV) Testing Revenue by Type (2021-2026) & (USD Million)
    Table 109. Europe Human Papillomavirus (HPV) Testing Revenue by Application (2016-2021) & (USD Million)
    Table 110. Europe Human Papillomavirus (HPV) Testing Revenue by Application (2021-2026) & (USD Million)
    Table 111. Europe Human Papillomavirus (HPV) Testing Revenue by Country (2016-2021) & (USD Million)
    Table 112. Europe Human Papillomavirus (HPV) Testing Revenue by Country (2021-2026) & (USD Million)
    Table 113. Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Type (2016-2021) & (USD Million)
    Table 114. Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Type (2021-2026) & (USD Million)
    Table 115. Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Application (2016-2021) & (USD Million)
    Table 116. Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Application (2021-2026) & (USD Million)
    Table 117. Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Region (2016-2021) & (USD Million)
    Table 118. Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Region (2021-2026) & (USD Million)
    Table 119. South America Human Papillomavirus (HPV) Testing Revenue by Type (2016-2021) & (USD Million)
    Table 120. South America Human Papillomavirus (HPV) Testing Revenue by Type (2021-2026) & (USD Million)
    Table 121. South America Human Papillomavirus (HPV) Testing Revenue by Application (2016-2021) & (USD Million)
    Table 122. South America Human Papillomavirus (HPV) Testing Revenue by Application (2021-2026) & (USD Million)
    Table 123. South America Human Papillomavirus (HPV) Testing Revenue by Country (2016-2021) & (USD Million)
    Table 124. South America Human Papillomavirus (HPV) Testing Revenue by Country (2021-2026) & (USD Million)
    Table 125. Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Type (2016-2021) & (USD Million)
    Table 126. Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Type (2021-2026) & (USD Million)
    Table 127. Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Application (2016-2021) & (USD Million)
    Table 128. Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Application (2021-2026) & (USD Million)
    Table 129. Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Country (2016-2021) & (USD Million)
    Table 130. Middle East & Africa Human Papillomavirus (HPV) Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Human Papillomavirus (HPV) Testing Picture
    Figure 2. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type in 2020
    Figure 3. Pap Smear Test
    Figure 4. HPV DNA Test
    Figure 5. Human Papillomavirus (HPV) Testing Revenue Market Share by Application in 2020
    Figure 6. Diagnostic Centers Picture
    Figure 7. Hospitals Picture
    Figure 8. Clinic Picture
    Figure 9. Global Human Papillomavirus (HPV) Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 10. Global Human Papillomavirus (HPV) Testing Revenue and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Region (2016-2026)
    Figure 12. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Region in 2020
    Figure 13. North America Human Papillomavirus (HPV) Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Europe Human Papillomavirus (HPV) Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Asia-Pacific Human Papillomavirus (HPV) Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. South America Human Papillomavirus (HPV) Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Middle East and Africa Human Papillomavirus (HPV) Testing Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Human Papillomavirus (HPV) Testing Market Drivers
    Figure 19. Human Papillomavirus (HPV) Testing Market Restraints
    Figure 20. Human Papillomavirus (HPV) Testing Market Trends
    Figure 21. Roche Recent Developments and Future Plans
    Figure 22. Agilent Technologies Recent Developments and Future Plans
    Figure 23. Becton, DickinsonandCompany Recent Developments and Future Plans
    Figure 24. QiagenN.V. Recent Developments and Future Plans
    Figure 25. Thermo FisherScientificInc. Recent Developments and Future Plans
    Figure 26. Abbott Laboratories Recent Developments and Future Plans
    Figure 27. HologicInc. Recent Developments and Future Plans
    Figure 28. CepheidInc. Recent Developments and Future Plans
    Figure 29. SeegeneInc. Recent Developments and Future Plans
    Figure 30. TakaraBio Inc. Recent Developments and Future Plans
    Figure 31. DaAnGeneof SunYat-SenUniversity Recent Developments and Future Plans
    Figure 32. PromegaCorporation Recent Developments and Future Plans
    Figure 33. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Developments and Future Plans
    Figure 34. Enzo Biochem Inc. Recent Developments and Future Plans
    Figure 35. NorgenBiotek Recent Developments and Future Plans
    Figure 36. DiagCorBioscienceIncLtd Recent Developments and Future Plans
    Figure 37. Hybribio Limited Recent Developments and Future Plans
    Figure 38. ZytovisionGmbH Recent Developments and Future Plans
    Figure 39. ArborVitaCorporation Recent Developments and Future Plans
    Figure 40. Medical& BiologicalLaboratoriesCo., Ltd Recent Developments and Future Plans
    Figure 41. Fujirebio Diagnostics Recent Developments and Future Plans
    Figure 42. Global Human Papillomavirus (HPV) Testing Revenue Share by Players in 2020
    Figure 43. Human Papillomavirus (HPV) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 44. Global Top 3 Players Human Papillomavirus (HPV) Testing Revenue Market Share in 2020
    Figure 45. Global Top 10 Players Human Papillomavirus (HPV) Testing Revenue Market Share in 2020
    Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 47. Global Human Papillomavirus (HPV) Testing Revenue Share by Type in 2020
    Figure 48. Global Human Papillomavirus (HPV) Testing Market Share Forecast by Type (2021-2026)
    Figure 49. Global Human Papillomavirus (HPV) Testing Revenue Share by Application in 2020
    Figure 50. Global Human Papillomavirus (HPV) Testing Market Share Forecast by Application (2021-2026)
    Figure 51. North America Human Papillomavirus (HPV) Testing Sales Market Share by Type (2016-2026)
    Figure 52. North America Human Papillomavirus (HPV) Testing Sales Market Share by Application (2016-2026)
    Figure 53. North America Human Papillomavirus (HPV) Testing Revenue Market Share by Country (2016-2026)
    Figure 54. United States Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Canada Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Mexico Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Europe Human Papillomavirus (HPV) Testing Sales Market Share by Type (2016-2026)
    Figure 58. Europe Human Papillomavirus (HPV) Testing Sales Market Share by Application (2016-2026)
    Figure 59. Europe Human Papillomavirus (HPV) Testing Revenue Market Share by Country (2016-2026)
    Figure 60. Germany Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. France Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. United Kingdom Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Russia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Italy Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Asia-Pacific Human Papillomavirus (HPV) Testing Sales Market Share by Type (2016-2026)
    Figure 66. Asia-Pacific Human Papillomavirus (HPV) Testing Sales Market Share by Application (2016-2026)
    Figure 67. Asia-Pacific Human Papillomavirus (HPV) Testing Revenue Market Share by Region (2016-2026)
    Figure 68. China Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Japan Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. South Korea Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. India Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Southeast Asia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Australia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. South America Human Papillomavirus (HPV) Testing Sales Market Share by Type (2016-2026)
    Figure 75. South America Human Papillomavirus (HPV) Testing Sales Market Share by Application (2016-2026)
    Figure 76. South America Human Papillomavirus (HPV) Testing Revenue Market Share by Country (2016-2026)
    Figure 77. Brazil Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Argentina Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Middle East and Africa Human Papillomavirus (HPV) Testing Sales Market Share by Type (2016-2026)
    Figure 80. Middle East and Africa Human Papillomavirus (HPV) Testing Sales Market Share by Application (2016-2026)
    Figure 81. Middle East and Africa Human Papillomavirus (HPV) Testing Revenue Market Share by Country (2016-2026)
    Figure 82. Turkey Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 83. Saudi Arabia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 84. UAE Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Roche
Agilent Technologies
Becton, DickinsonandCompany
QiagenN.V.
Thermo FisherScientificInc.
Abbott Laboratories
HologicInc.
CepheidInc.
SeegeneInc.
TakaraBio Inc.
DaAnGeneof SunYat-SenUniversity
PromegaCorporation
GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
Enzo Biochem Inc.
NorgenBiotek
DiagCorBioscienceIncLtd
Hybribio Limited
ZytovisionGmbH
ArborVitaCorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics

Related Reports

Global Human Papillomavirus (HPV) Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Human Papillomavirus (HPV) Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 08 Jan 2022

date Medical Care

Product Tags

human papillomavirus hpv testing

Human Papillomavirus (HPV) Testing

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>